1.Prof.Panjing gave an oral presentation on the theme of"DONOR-DERIVED CD5 CAR-T CELLS FOR T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA"2.Prof.Liu Shuangyou made a poster display with the theme of"THE TREATMENT RESPONSE OF A TWO-DOSE REGIMEN OF DOSE-ADJUSTED INOTUZUMAB IN RELAPSED/REFRACTORY B-ALL"3.Dr.Zheng Peihao made a poster display with the theme of"DURABLE REMISSION AFTER SEQUENTIAL CD19/20 CAR-T-CELL“CAKE-ICING”THERAPY OCCURRED IN REFRACTORY/RELAPSED DLBCL"4.Prof.Yangfan made a poster display with the theme of"EARLY ADMINISTRATION OF POLATUZUMAB VEDOTIN AS BRIDGING CD19-SPECIFIC CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY IS AN EFFECTIVE STRATEGY TO IMPROVE SURVIVAL IN PATIENTS WITH R/R B-CELL LYMPHOMA"5.Dr.Guo Yuelu made a poster display with the theme of"A PROSPECTIVE STUDY OF TARGETED SEQUENTIAL IMMUNOTHERAPY.IN PATIENTS WITH RELAPSED REFRACTORY PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA"6.Prof.Zhenq Qinlong made a poster display with the theme of"IMPACT OF ARID1A AND TP53 MUTATIONS IN …

1.Prof.Li Zhihui gave an oral presentation on the theme of"CD7 chimeric antigen receptor T-cells bridging to allogeneic hematopoietic stem cell transplantation improved disease-free survival in refractory/relapsed T-cell acute lymphoblastic leukemia"2.Dr.Ma Lixia made a poster display with the theme of"Gastrointestinal bleeding significantly reduced the efficacy and survival of CD19 CAR-T cell therapy in patients with gastrointestinal tract involvement of refractory/relapsed B-cell lymphoma"3.Prof.Yang Fan made a poster display with the theme of"Efficacy and toxicity for CD7 chimeric antigen receptor T-cell therapy in patients with relapsed/refractory T-cell lymphoma"4.Dr.Feng Shaomei was selected as the abstract of the paper on the topic"Influence of previous radiotherapy on the effect of CAR-T cell therapy in aggressive B-cell lymphoma"

1.Dr.Tan Yue gave an oral report on"DONOR-DERIVED CD7 CAR-T CELLS FOR T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA"2.Dr.Tang Kaiting gave an oral report on"LONG-TERM FOLLOW-UP OF SEQUENTIAL CD19-22 CAR-T-CELL THERAY IN 20 CHILDREN WITH REFRACTORY OR RELAPSED B-ALL"3.Dr.Shi Hui gave an oral report on"GENETIC LANDSCAPES AND CURATIVE EFFECT OF CAR-T CELLS IMMUNOTHERAPY IN RELAPSE AND REFRACTORY DLBCLS"4.Dr.Zhao Defeng made a poster display with the theme of"CD22-TAGETED CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY FOR ADULTS WITH REFRACTORY OR RELAPSED B ACUTE LYMPHOBLASTIC LEUKEMIA"5.Dr.An Lihong made a poster display with the theme of"THE SALVAGE TREATMENT OF HUMANIZED-CD19 CAR-T CELLS FOR RELAPSED B-ALL AFTER PRIOR MURINIZED-CD19 CAR-T CELL THERAPY"6.Dr.Guo Yuelu made a poster display with the theme of"TUMOR CHARACTERISTICS OF DISEASE PROGRESSION AFTER BCMA-CAR-T TREATMENT OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA WITH EXTRAMEDULLARY LESIONS"7.Dr.Yang Fan made a poster display with the theme of"H…

The 25th European Hematology Annual Meeting (EHA) was held online for the first time, at which Chinese research teams were selected for 12 oral presentations and 78 poster presentations. Among them, Gaobo Medical Group presented a total of 15 outstanding achievements in EHA2020 with 2 oral speeches at the conference, 11 poster displays and 2 abstracts. Among them, the team of Beijing Boren Hospital achieved a total of 11 good results including 1 oral, 9 wall, and 1 abstract.

1.Dr.Pan Jing's two CAR-T-related research results were presented in posters.2.Dr.Li Zhihui reported"IDENTIFYING RELATIONSHIP BETWEEN HEREDITARY PREDISPOSITION GENE AND COMPLICATIONS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ACUTE LEUKEMIA"3.Dr.Zhang Wenqun reported"Chimeric antigen receptor T-cells(CAR-T)for refractory and relapsed Burkitt's lymphoma:early response in pediatric patients"

Dr.Pan Jing gave an oral presentation on the theme of "Efficacy and safety of CD22-CAR-T cell therapy in 15 children with refractory relapsed B-cell acute lymphoblastic leukemia"